Bank of America’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q2 | – | Sell |
-227,221
| Closed | -$4.42M | – | 6670 |
|
2018
Q1 | $4.42M | Buy |
227,221
+12,920
| +6% | +$251K | ﹤0.01% | 2781 |
|
2017
Q4 | $3.57M | Buy |
214,301
+25,671
| +14% | +$428K | ﹤0.01% | 2930 |
|
2017
Q3 | $3.83M | Sell |
188,630
-9,348
| -5% | -$190K | ﹤0.01% | 2943 |
|
2017
Q2 | $3.19M | Buy |
197,978
+10,585
| +6% | +$170K | ﹤0.01% | 2975 |
|
2017
Q1 | $2.37M | Buy |
187,393
+87,867
| +88% | +$1.11M | ﹤0.01% | 3190 |
|
2016
Q4 | $1.32M | Buy |
99,526
+34,216
| +52% | +$453K | ﹤0.01% | 3505 |
|
2016
Q3 | $1.55M | Buy |
65,310
+10,012
| +18% | +$237K | ﹤0.01% | 3272 |
|
2016
Q2 | $1.59M | Sell |
55,298
-2,820
| -5% | -$81.2K | ﹤0.01% | 3214 |
|
2016
Q1 | $1.86M | Buy |
58,118
+18,577
| +47% | +$595K | ﹤0.01% | 3026 |
|
2015
Q4 | $1.69M | Sell |
39,541
-2,359
| -6% | -$101K | ﹤0.01% | 3191 |
|
2015
Q3 | $1.48M | Sell |
41,900
-31,817
| -43% | -$1.12M | ﹤0.01% | 3273 |
|
2015
Q2 | $3.39M | Buy |
73,717
+69,361
| +1,592% | +$3.18M | ﹤0.01% | 2315 |
|
2015
Q1 | $204K | Sell |
4,356
-10,809
| -71% | -$506K | ﹤0.01% | 4010 |
|
2014
Q4 | $480K | Buy |
15,165
+6,157
| +68% | +$195K | ﹤0.01% | 3609 |
|
2014
Q3 | $214K | Buy |
9,008
+1,200
| +15% | +$28.5K | ﹤0.01% | 4022 |
|
2014
Q2 | $234K | Sell |
7,808
-26,109
| -77% | -$782K | ﹤0.01% | 4107 |
|
2014
Q1 | $896K | Sell |
33,917
-37,401
| -52% | -$988K | ﹤0.01% | 3127 |
|
2013
Q4 | $1.79M | Buy |
71,318
+10,754
| +18% | +$270K | ﹤0.01% | 2620 |
|
2013
Q3 | $1.24M | Buy |
60,564
+764
| +1% | +$15.6K | ﹤0.01% | 2830 |
|
2013
Q2 | $1.19M | Buy |
+59,800
| New | +$1.19M | ﹤0.01% | 2977 |
|